Research

Notion · Lifecycle autopsy

How a product at that valuation fumbles user activation.

A full lifecycle autopsy of Notion’s post-signup experience: every email, every trigger, every gap between what signup collects and what the lifecycle does with it.

  • 53pages, every claim traced to observable behaviour or a cited source
  • 0internal Notion data used

The finding

Notion asks the right questions. The lifecycle ignores the answers.

Notion’s signup flow asks new users what they’re here for, whether it’s work or personal, and roughly what they intend to build. By the time someone lands in the product, Notion knows more about their intent than most SaaS companies learn in a month.

The lifecycle then does almost nothing with it. Users self-identify at the door and get routed into a sequence that treats every one of them identically: the same nudges, the same templates, the same cadence, regardless of what they said they came to do.

Why it matters

The blank page is the activation problem.

A tool that can be anything is a tool that is nothing until the user builds the first useful thing. Activation isn’t signup and it isn’t a login. It’s the moment the product holds something the user would be annoyed to lose.

Everything in the lifecycle should be aimed at that moment, and the intent captured at signup is the most direct route to it.

The method

Every claim traced, not asserted.

The autopsy maps the observed journey end to end and sets it against what the product already knew about the user. Where the two diverge is where activation quietly leaks.

It runs to 53 pages because every claim is traced to an observable behaviour or a cited source. That is the same standard we hold a client investigation to, which is the point of publishing it.

What happened next

…led to a genuinely insightful discussion on customer lifecycles, production adoption, and AI.

Áine DundasHead of EMEA Marketing, NotionPosted publicly after the conversation that followed publication. Her words describe the conversation; Notion has not commented on the findings.

Find the revenue you’re losing.

Tell us where you think it breaks. We’ll show you what the evidence says.